glp 1 and crohn's Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential The role of GLP-1 RA
Description
Nothing artificial

Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects...

In India, GLP-1 drugs can only be prescribed by endocrinologists, internal medicine specialists, and cardiologists

How long has Zepbound been around
The novel synergistically acting glucagon-like peptide-1 (GLP-1) receptor agonist combined with the amylin agonist, CagriSema, shows promising results in both glucose regulation and weight management

p=0.030) and 25% higher at 12 months (95% CI: 2 to 59
